DNA -
Ginkgo Bioworks Holdin
7.59
+0.91 (+13.62%)
As of April 14, 2026 3:23 pm EDT
Quote Detail
| Last | 7.59 |
|---|---|
| Change | 0.91 |
| Change % | 13.62 |
| Bid | 7.58 X 700 |
| Ask | 7.6 X 100 |
| Volume | 1.7 M |
| Shares | 58.36 M |
| Market Cap | 389.83 M |
| Open | 6.82 |
|---|---|
| High | 7.87 |
| Low | 6.79 |
| Prev Close | 6.68 |
| 52 Wk High | 17.58 |
| 52 Wk Low | 5.37 |
| EPS | -5.6837 |
| P/E | n.a. |
| Div Yield | n.a. |
Market Headlines
Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
BOSTON, March 2, 2026 /PRNewswire via COMTEX News Network/ -- Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to...
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
BOSTON, Feb. 26, 2026 /PRNewswire via COMTEX News Network/ -- Ginkgo provides an update on its fourth quarter financial results
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation
BOSTON, Feb. 19, 2026 /PRNewswire via COMTEX News Network/ -- Presentation and Q&A session scheduled for post-market on Thursday, February 26, 2026
Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products
BOSTON, Feb. 18, 2026 /PRNewswire via COMTEX News Network/ -- -- Collaboration aims to develop a commercialization-ready microorganism to manufacture next-generation...
